invivodata’s DiaryPRO Collects Primary Endpoint Data for Phase II Clinical Study

invivodata’s DiaryPRO solution used by patients to report daily pain frequency and severity.

This article is located at another site and will open a new window or tab in your browser. Some links may require Adobe Acrobat Reader. To continue reading, please click here:

http://www.invivodata.com/corp/invivodata_Depomed.htm?print=1

Press Relations Contact

Britney Grimmelsman

Email: bg@rccf.com

Phone: 513-621-9700

Portfolio Companies

Nielsen BuzzMetrics

Testimonial

MX Logic

Testimonial

ifbyphone

Testimonial

Health Integrated

Testimonial

EVault

Testimonial

Trax Technologies

Testimonial

Univa UD

Testimonial

ISD Holdings

Testimonial

Simbionix

Testimonial

OrthoScan, Inc.

Testimonial

MedPlast

Testimonial

Intradiem

Testimonial

Stay Updated

Stay connected by subscribing to our quarterly e-newsletter. Get the latest news and updates sent right to your inbox..

Web Form Builder